Life Sciences
0
Novogene Europe launches untargeted metabolomics service through Cambridge Omics Centre
0

The new LC-MS-based service expands the company’s multiomics portfolio, enabling researchers to integrate metabolite profiling with ...

0
Dealmaking in the Age of AI: IP, Licensing, and Spin-Out Strategies for AI-Enhanced Drug Discovery
0

This is the third in a series of blog posts focused on AI and clinical trials/research space, highlighting topics to be discussed at the upcoming BIO ...

0
OpenAI-Backed Chai Discovery Raises $130M to Tackle “Undruggable” Targets with Generative AI
0

What You Should Know:  – Chai Discovery has secured a $130M Series B financing round, propelling its valuation to $1.3 billion just months after ...

0
Attorney General Pam Bondi’s Memo Concerning Healthcare Treatment for Transgender Minors: Implications for Providers
0

Attorney General Pam Bondi’s Memo Concerning Healthcare Treatment for Transgender Minors: Implications for Providers | Healthcare Law ...

0
Mission Bio Unveils Industry-First Single-Cell Genotype and Targeted Gene Expression Solution –
0

What You Should Know: – Mission Bio, a leader in single-cell multiomics solutions for precision medicine, today announced the launch of its ...

Show next
Som2ny Network
Logo
Register New Account
Compare items
  • Total (0)
Compare
0
Shopping cart